Oncology Central
  • Home
  • News
  • Insights
    • Insights
      • Opinion
      • Columnists
      • Journal articles
      • Events
      • Spotlights
      • In focus
      • Follow us on social media
  • Topics
    • Disease area
      • Skin
      • Breast
      • Colorectal
      • Hematologic
      • Lung
      • View all
      • Follow us on social media
    • Subject area
      • Immuno-oncology
      • Clinical trials
      • Genetics
      • Preclinical research and trials
      • Prevention and screening
      • Therapies
      • View all
  • Multimedia
    • Multimedia
      • Videos
      • Podcasts
      • Infographics
      • Webinars
      • Follow us on social media
  • Register
  • i
  • i
  • i
  • Home
  • News
  • Insights
    • Opinion
    • Columnists
    • Journal articles
    • Spotlights
    • In Focus
    • Events
  • Topics
    • Disease area
      • Skin
      • Breast
      • Colorectal
      • Hematologic
      • Lung
      • View all
    • Subject area
      • Immuno-oncology
      • Clinical trials
      • View all
  • Multimedia
    • Videos
    • Infographics
    • Podcasts
    • Webinars
  • Registration
  • Follow us on social media
  • i
  • i

Login

Please enter your username and password below, if you are not yet a member of Oncology Central remember you can register for free.

Forgot your password?

Already have an account? Login here

Already have an account? Login here

Most searched
  • vitamin c
  • hiv and lymphoma
  • breast conserving surgery
  • Ncri 2019
  • ncri

drug approval

  • 20 Sep 2018 CAR-T therapy

    NICE rejects Kymriah® for adults with lymphoma

  • 17 Sep 2018

    NICE approves dabrafenib–trametinib for BRAF+ melanoma

  • 5 Sep 2018

    Kymriah® is set to become the first CAR-T therapy available on the NHS

  • 29 Aug 2018 CAR-T therapy

    CAR-T therapy Yescarta get EU green light but meets resistance from NICE

  • 21 Aug 2018 Drug development

    Chinese regulators approve Alecensa® for NSCLC, hot on heels of FDA and EMA approvals

  • 3 Aug 2018

    FDA approves first-in-class treatment for rare adrenal tumors

  • 17 May 2018

    NICE approves atezolizumab for advanced bladder cancer patients on the NHS

  • 21 Feb 2018 Drug development

    Approval granted for novel non-small cell lung cancer drug

  • 17 Jan 2018 Industry and business

    Keytruda wows again; olaparib approval; CELESTIAL data: industry news round-up

  • 15 Jan 2018 Breast

    Olaparib becomes the first drug approved for BRCA breast cancer

  • About us
  • Contact Us
  • Our journals
  • Advertising & Sponsorship
  • Ambassadors
  • Twitter
  • Facebook
  • Linkedin
  • RSS
  • Oncology Central Newsletter

    Like our content? Subscribe to our weekly newsletter for news & articles direct to your inbox.


    Stay connected
    • Twitter
    • Facebook
    • Linkedin
    • RSS
  • Registration

    When you create your free account, you will be able to view all articles in full and see content personally tailored for you. Register here.

    Office Info

    Oncology Central is powered by Future Science Group.
    Unitec House, 2 Albert Place, London, N3 1QB, UK,
    +44 (0)20 8371 6090

    • About us
    • Contact Us
    • Our journals
    • Advertising & Sponsorship
    • Ambassadors
    • Registration

      When you create your free account, you will be able to view all articles in full and see content personally tailored for you. Register here.

      Office Info

      Oncology Central is powered by Future Science Group.
      Unitec House, 2 Albert Place, London, N3 1QB, UK,
      +44 (0)20 8371 6090

  • Future Science Group
  • Cookies Policy
  • Privacy Policy
  • Terms & Conditions
  • ©2019 Oncology Central
© 2018 Oncology Central